These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Is there a role for parathyroid hormone in humoral hypercalcemia of malignancy? Stewart AF Miner Electrolyte Metab; 1982; 8(3-4):215-26. PubMed ID: 6300632 [No Abstract] [Full Text] [Related]
4. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton. Stewart AF J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005 [TBL] [Abstract][Full Text] [Related]
6. [The role of a parathyroid hormone analogue in the pathogenesis of malignant hypercalcemia]. Rizzoli R; Buchs B; Pizurki L; Caverzasio J; Sappino AP; Vadas L; Arlot M; Bonjour JP Pathol Biol (Paris); 1990 Jun; 38(6):656-64. PubMed ID: 2197594 [TBL] [Abstract][Full Text] [Related]
7. [Hypercalcemia and malignancies; pathogenesis, differential diagnosis and treatment]. Slee PH; Koppeschaar HP; Nortier JW; Raymakers JA Ned Tijdschr Geneeskd; 1992 Jun; 136(26):1243-7. PubMed ID: 1620252 [No Abstract] [Full Text] [Related]
8. Differentiation of hypercalcaemia due to malignancy from primary hyperparathyroidism: the value of parathyroid hormone and plasma bicarbonate measurements. Freaney R; Ryan E; Muldowney FP Ir J Med Sci; 1981 Jan; 150(1):6-12. PubMed ID: 7216714 [No Abstract] [Full Text] [Related]
9. Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia. Nakayama K; Fukumoto S; Takeda S; Takeuchi Y; Ishikawa T; Miura M; Hata K; Hane M; Tamura Y; Tanaka Y; Kitaoka M; Obara T; Ogata E; Matsumoto T J Clin Endocrinol Metab; 1996 Feb; 81(2):607-11. PubMed ID: 8636276 [TBL] [Abstract][Full Text] [Related]
10. [Hypercalcemia and neoplasms]. Rossetti A; Taliani U; Pioli G; Sansoni P G Clin Med; 1987; 68(6-7):335-8, 340-5. PubMed ID: 2888700 [No Abstract] [Full Text] [Related]
11. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653 [TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of hypercalcemia associated with malignant tumors]. François D; Body JJ; Nijs-De Wolf N; Fuss M; Gillet C; Corvilain J Rev Med Brux; 1987; 8(6-7):359-62. PubMed ID: 2823362 [No Abstract] [Full Text] [Related]
17. Ectopic secretion of parathyroid hormone. Max MH; Lawrence PH Surg Gynecol Obstet; 1980 Mar; 150(3):411-8. PubMed ID: 6986669 [TBL] [Abstract][Full Text] [Related]
18. Hypercalcaemia in patients with advanced mammary cancer. Galasko CS; Burn JI Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456 [TBL] [Abstract][Full Text] [Related]
19. [Malignant neoplasms and calcium metabolism (a review of the literature)]. Kashulina AP; Tereshchenko IP Patol Fiziol Eksp Ter; 1973; 17(5):84-8. PubMed ID: 4789470 [No Abstract] [Full Text] [Related]
20. [Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis]. Blind E; Raue F; Zisterer A; Kohl B; Ziegler R Dtsch Med Wochenschr; 1990 Nov; 115(46):1739-45. PubMed ID: 2226185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]